Taiwanese developer of microfluidic testing equipment for early cancer screening.
Industry: Health Care
Latest Trade: $1.27 0.00 (0.0%)
First Day Return: -8.8%
Return from IPO: -68.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/22/2023 |
Offer Price | $4.00 |
Price Range $4.00 - $6.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/05/2025 |
Offer Price | $4.00 |
Price Range $4.00 - $6.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Craft Capital Management |
Company Data | |
---|---|
Headquarters | Tainan, Taiwan |
Founded | 2014 |
Employees at IPO | 40 |
Website www.advanbiomed.com |